Stay updated on GEMINI 1 Tolebrutinib Clinical Trial
Sign up to get notified when there's something new on the GEMINI 1 Tolebrutinib Clinical Trial page.

Latest updates to the GEMINI 1 Tolebrutinib Clinical Trial page
- Check5 days agoChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the footer revision number changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe ClinicalTrials.gov footer revision advanced from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page now shows a 403 Forbidden error with a minimal header and a Home button, replacing the expected study record details. This indicates restricted access to the content rather than an update to the study data.SummaryDifference17%

- Check40 days agoChange DetectedThe page revision tag was updated to v3.7.0, indicating a newer iteration of the site template or rendering. The change does not modify the study details or user-facing content.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision changed from v3.6.5 to v3.6.6 on the page. This marks an update to the page's version metadata.SummaryDifference0.0%

- Check75 days agoChange DetectedAdds a new citation for 'Tolebrutinib liver safety: A detailed overview' by Maxwell et al., expanding the page’s bibliography with author names. The page revision is updated to v3.6.5, while the prior plain language results summary, Sanofi branding, 'Helpful Links Provided by', and the v3.6.4 revision tag are removed.SummaryDifference0.1%

Stay in the know with updates to GEMINI 1 Tolebrutinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEMINI 1 Tolebrutinib Clinical Trial page.